Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

248
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
248
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

73
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
73
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

642
Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
642
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

549
This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
549
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

143
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
143
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

39
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
39

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should we use fat-free mass or body mass and percentage body fat as separate predictors to predict maximum oxygen uptake?

BMJ open sport & exercise medicine·2026
Same author

The unpredictable talent selection in youth beach handball players.

Journal of sports sciences·2025
Same author

Assessing Change of Direction and Neuromuscular Power in Children: Insights From an Allometric Approach in Mediterranean Youth.

Perceptual and motor skills·2025
Same author

Laser hair depilation therapy for pilonidal sinus disease: a 5-year, retrospective experience in a university teaching hospital in the UK, 2017-2023.

Clinical and experimental dermatology·2025
Same author

Improving event prediction using general practitioner clinical judgement in a digital risk stratification model: a pilot study.

BMC medical informatics and decision making·2024
Same author

Oral ethanol prescribing for alcohol withdrawal syndrome: initial findings and future directions following implementation within a United Kingdom National Health Service setting.

Clinical toxicology (Philadelphia, Pa.)·2024

Related Experiment Video

Updated: May 21, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

Community-based cardiovascular risk assessment using the CardisioTM AI test: a prospective cohort study.

Simon V Rudland1, Nisar H Shah2, Alan Nevill3

  • 1Integrated Care Academy, University of Suffolk, Ipswich, UK s.rudland@nhs.net.

BJGP Open
|May 19, 2025
PubMed
Summary

The Cardisio test effectively identifies cardiovascular disease in high-risk individuals in community settings. This AI-powered tool offers a more effective near-patient screening than traditional ECGs.

Keywords:
cardiovascular diseasesclinical diagnosishealth inequitiesinequalitiesprimary health care

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

326

Related Experiment Videos

Last Updated: May 21, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

326

Area of Science:

  • Cardiology
  • Artificial Intelligence in Healthcare
  • Public Health

Background:

  • Cardiovascular disease (CVD) poses a significant health burden, particularly in underserved populations.
  • Health inequalities in CVD diagnosis and care persist due to access barriers.
  • Innovative community-based testing technologies can help bridge these gaps.

Purpose of the Study:

  • To evaluate the Cardisio test's ability to detect asymptomatic cardiovascular disease.
  • To assess the utility of a cloud-based AI algorithm interpreting 3D vectorcardiography.
  • To explore a novel approach for community-based cardiovascular screening.

Main Methods:

  • Prospective cohort study conducted in general practice, pharmacy, and community health centers.
  • Recruitment of asymptomatic adults (≥18 years) with elevated CVD risk (QRISK3 score ≥10%).
  • A 10-minute Cardisio test using five electrodes, with results classified by AI into red, amber, or green categories.

Main Results:

  • 628 tests were performed on adults aged 18-75, with 51% males.
  • A significant association was found between "red" Cardisio test results and the need for cardiology referral (p<0.001).
  • The test was rated as easy to perform, with an 87.5% participant recommendation rate.

Conclusions:

  • The Cardisio test is a simple, near-patient tool for identifying underlying cardiovascular disease.
  • It provides better identification of CVD in high-risk, hard-to-reach individuals compared to traditional 12-lead ECG.
  • This technology facilitates new care pathways and addresses health inequalities.